# Benzonatate

NDC: 62135-441
Generic name: Benzonatate
Labeler / Manufacturer: Chartwell RX, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20180501

FDA application: ANDA040682

## Active ingredients

- BENZONATATE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62135-441"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62135-441
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a17033c-1ad3-4c7a-92ee-f55756833986